| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000013817 |
| Receipt No. | R000016126 |
| Official scientific title of the study | Jikei-Evaluation of basal insulin analogue on (nocturnal) glycemic variability with continuous glucose monitoring -existing basal insulin analogue versus Tresiba ; insulin degludec - a new basal insulin analogue, in basal-bolus treatment in type 1 diabetes- |
| Date of disclosure of the study information | 2014/04/26 |
| Last modified on | 2016/10/26 (Ver. 8) |
| Basic information | ||
| Official scientific title of the study | Jikei-Evaluation of basal insulin analogue on (nocturnal) glycemic variability with continuous glucose monitoring
-existing basal insulin analogue versus Tresiba ; insulin degludec - a new basal insulin analogue, in basal-bolus treatment in type 1 diabetes- |
|
| Title of the study (Brief title) | JET-1 | |
| Region |
|
|
| Condition | ||
| Condition | Type 1 diabetes | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | We compare glucose control of Degludec to ohter long-acting basal insulin analogue in Japanese patient with type 1 diabetes |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Continuous glucose value of 24 hours by CGM |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | insulin degludec | |
| Interventions/Control_2 | long-acting insulin analogue other than insulin degludec | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Type 1 diabetes receiving Basal-bolus insulin therapy. | |||
| Key exclusion criteria | Type 2 diabetes. | |||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Rimei NIshimura |
| Organization | The Jikei University School of Medicine |
| Division name | Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine |
| Address | 3-25-8 Nishishinbashi, Minato-ku, Tokyo,Japan |
| TEL | +81334331111 |
| rimei@jikei.ac.jp | |
| Public contact | |
| Name of contact person | Rimei NIshimura |
| Organization | The Jikei University School of Medicine |
| Division name | Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine |
| Address | 3-25-8 Nishishinbashi, Minato-ku, Tokyo,Japan |
| TEL | +81334331111 |
| Homepage URL | |
| rimei@jikei.ac.jp | |
| Sponsor | |
| Institute | The Jikei University School of Medicine Japan Diabetes Foundation |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japan Diabetes Foundation |
| Organization | |
| Division | |
| Category of Funding Organization | Non profit foundation |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | Comparison of glycemic variability in Japanese patients with type 1 diabetes receiving insulin degludec versus insulin glargine using continuous glucose monitoring: A randomized, cross-over, pilot study.
Onda Y, Nishimura R, Ando K, Takahashi H, Tsujino D, Utsunomiya K. Diabetes Res Clin Pract. 2016 Oct;120:149-55. doi: 10.1016/j.diabres.2016.07.019. |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000016126 |